Telehealth Patient Retention: The Churn Math That Decides Whether Your Ads Are Profitable

Why does retention decide whether telehealth ads are profitable?

Retention decides telehealth ad profitability because acquisition cost is paid once and recovered in monthly installments. A brand that spends $150 to acquire a patient billing $199 per month at 50 percent gross margin earns about $100 of contribution per month, so it needs roughly 1.5 months of retention just to break even on media and closer to 3 months once agency fees, creative, and platform costs are counted. Every month the patient stays past that point is profit, and every month lost to churn is profit that never arrives.

This is what separates telehealth from a one-time purchase. In a booked-procedure or single-transaction model, the sale either covers acquisition or it does not, and you know on day one. In a subscription model the same acquisition can be highly profitable or a net loss depending entirely on how long the patient stays, and you do not know which until the cohort ages. That is why ClinicAds treats churn as an ad metric rather than a customer-success metric. The churn rate is upstream of the CAC target, the budget, and the profitability of the entire program. These are agency averages, not guarantees.

What is a healthy monthly churn rate for telehealth?

A healthy monthly churn rate for a DTC telehealth subscription runs from about 5 percent in sticky clinical verticals to 15 percent or higher in verticals where patients reach a goal and stop. Hormone and TRT patients, who treat an ongoing condition, churn slowest. GLP-1 weight-loss and mental-health patients churn fastest because many reach a target or resolve an episode and cancel. The table below shows the ranges ClinicAds sees, alongside the average months retained each implies. Average months retained is roughly one divided by the monthly churn rate, so small churn differences compound into large lifetime-value gaps.

The practical takeaway is that there is no single telehealth churn benchmark. A 10 percent monthly churn rate is a warning sign in hormone therapy and a strong result in GLP-1 weight loss. Judge a brand's churn against its vertical, not against a blended DTC average, because the vertical sets the ceiling on how sticky the subscription can realistically be. These are agency averages, not guarantees.

How does churn compound across a telehealth cohort?

Churn compounds because it applies to whoever is still subscribed each month, so a cohort shrinks geometrically rather than linearly. The gap between a good churn rate and a poor one looks small monthly and enormous over a year. At 6 percent monthly churn, about 48 percent of a starting cohort is still paying at month 12. At 12 percent monthly churn, only about 22 percent remains. A 6-point difference in a single month's rate more than doubles the share of the cohort that survives to a year.

This is why chasing acquisition volume without fixing churn is a leaking bucket. Two telehealth brands can acquire the same 1,000 patients a month at the same CAC, and a year later one has a paying base more than twice the size of the other purely on the retention curve. The table below traces a single 1,000-patient cohort through its first year at three monthly churn rates so the compounding is visible. These are agency averages, not guarantees.

What CAC can a telehealth brand afford at each churn rate?

The maximum CAC a telehealth brand can afford is its contribution lifetime value divided by its target LTV-to-CAC ratio, and churn drives the lifetime-value term directly. Hold monthly contribution at $100, meaning a $199 charge at roughly 50 percent gross margin, and hold the target at 3:1. Average months retained is one divided by the monthly churn rate, so lifetime value and the affordable CAC fall as churn rises. The table below runs five churn rates through that math.

The spread is the whole point. At 5 percent monthly churn the brand can profitably pay about $667 to acquire a patient. At 15 percent it can pay only about $222 for the identical margin and target. Since ClinicAds sees paying-patient CAC of $90 to $250 across telehealth verticals, a brand at 12 to 15 percent churn is operating with almost no headroom, while a brand at 5 to 8 percent churn has room to outbid competitors for the same demand. Churn does not just lower profit, it decides whether you can afford to compete in the auction at all. These are agency averages, not guarantees.

Where and when do telehealth patients churn?

Telehealth churn is front-loaded, meaning the largest share of cancellations happens in the first 90 days, often in the first billing cycle. A patient who never completes the intake, never gets the first fill shipped, or has an unmanaged early side effect cancels before the subscription ever had a chance to pay back CAC. A blended monthly churn rate averages these early losses across the whole base and understates how much risk sits in the first three months, which is exactly the window that determines whether acquisition was profitable.

Because of this, ClinicAds tracks first-fill rate and first-90-day retention as separate numbers from the steady-state monthly churn rate. A brand can show a respectable 8 percent blended monthly churn while quietly losing 25 to 35 percent of new patients before month three, and no amount of ad optimization fixes a funnel that acquires patients who never activate. The early window is an onboarding and clinical-fit problem, not a media problem, and it is usually the single highest-return place to work. These are agency averages, not guarantees.

• ·First-fill or first-appointment completion, the first place a paid patient is lost before any revenue clears
• ·Month one to month three, where unmanaged side effects and unmet expectations drive the steepest cancellations
• ·The steady-state tail after month three, where churn settles to the vertical's baseline monthly rate

How do you reduce telehealth patient churn?

You reduce telehealth churn by protecting the first 90 days and by giving patients a clinical reason to stay past their initial goal. The highest-return work is operational rather than creative, because most churn is decided by what happens after the sale. ClinicAds works the levers below in roughly this order, since the first three move the front-loaded early churn that does the most damage to CAC recovery, while the last two extend the steady-state tail. These are agency averages, not guarantees.

• ·1. Compress time to first fill or first appointment, since every day of delay between charge and treatment raises first-cycle cancellation
• ·2. Build a structured month-one check-in to manage side effects early, the most common unforced cause of first-90-day churn in GLP-1 and hormone care
• ·3. Match acquisition targeting to clinical fit, because patients acquired on an off-message promise churn fastest regardless of onboarding quality
• ·4. Offer a discounted multi-month or annual plan, which both extends committed retention and pulls contribution forward to shorten payback
• ·5. Add a maintenance or step-down protocol for goal-reaching verticals like GLP-1, giving patients a clinical reason to stay subscribed after the initial target

Should you measure churn on a blended or cohort basis?

Measure telehealth churn on a cohort basis, tracking each month's acquired patients as their own group over time, rather than blending all patients into one monthly rate. A blended rate mixes new patients, who churn fastest, with a long-tenured base, who churn slowly, and the resulting average hides both the early cliff and the true steady-state rate. When a brand scales acquisition, the blended rate also gets worse for a purely mechanical reason, more new patients in the mix, which can look like a retention problem that does not exist.

Cohort measurement separates those signals. It shows the first-90-day survival of each intake month, whether onboarding changes are actually working, and what the mature monthly churn rate settles to once a cohort ages past the early window. ClinicAds runs telehealth accounts on cohort retention curves for the same reason it trusts payback period over the LTV-to-CAC ratio: a cohort curve is measured history, while a blended monthly rate is an average that can move for reasons unrelated to how well patients are actually being retained. These are agency averages, not guarantees.

Does verified tracking change your measured churn and CAC?

Verified server-side tracking does not change true churn, but it changes the CAC and the profitability you measure against that churn. Client-side pixels increasingly miss conversions to browser privacy controls and ad blockers, which undercounts acquired patients and inflates the CAC a telehealth brand reports. An inflated CAC makes the churn-to-CAC relationship look worse than it is and can trigger budget cuts on a program that is actually clearing its retention hurdle.

For telehealth specifically, the tracking has to be HIPAA-compliant, because the FTC actions against BetterHelp and Cerebral centered on health data leaking through advertising pixels. ClinicAds implements server-side tracking that passes conversion signal without exposing protected health information, so the CAC in the model is the real CAC and the affordable-CAC math above is built on an honest number. Getting the denominator right matters as much as the churn rate, since profitability is the relationship between the two. These are agency averages, not guarantees.